This excerpt taken from the SWY DEF 14A filed Apr 4, 2007.
PRODUCTS OF CLONING OR GENETIC ENGINEERING
The Company has been notified by the Adrian Dominican Sisters, 1257 East Sienna Heights Drive, Adrian, MI 49221-1793, which owns 150 shares of Common Stock, that it intends to present, jointly with ASC Investment Group, Bon Secours Health System, Inc., Boston Common Asset Management, LLC, the Dominican Sisters of Oxford, MI, the Dominican Sisters of Springfield Illinois and the General Board of Pension and Health Benefits of the United Methodist Church, the following proposal for consideration at the Annual Meeting:
Label Products of Cloning or Genetic Engineering
RESOLVED: Shareholders request that the Board of Directors adopt a policy to identify and label all food products manufactured or sold by the company under the companys brand names or private labels that may contain genetically engineered (GE) ingredients or products of animal cloning.